Related references
Note: Only part of the references are listed.Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013
Ahmedin Jemal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J. Press et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Low utility of Oncotype DX® in the clinic
Luisel J. Ricks-Santi et al.
CANCER MEDICINE (2017)
The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer
Amber A. Guth et al.
BREAST JOURNAL (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Genomic profiling of breast cancer in African-American women using MammaPrint
Raquel A. Nunes et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Underutilization of gene expression profiling for early-stage breast cancer in California
Rosemary D. Cress et al.
CANCER CAUSES & CONTROL (2016)
Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer
Megan C. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Patterns of 21-Gene Assay Testing and Chemotherapy Use in Black and White Breast Cancer Patients
Vanessa B. Sheppard et al.
CLINICAL BREAST CANCER (2015)
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Erica T. Warner et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
Joseph A. Sparano et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
Soonmyung Paik
ONCOLOGIST (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
